IL-17 and IL-22 cytokines have been directly implicated in BCC and SCC progression and tumor growth in mouse xenografts, as well as progression, cell migration, and local invasion in BCC cancer cell lines (25). This evidence concerns the gene IL17A and skin basal cell carcinoma.